Finally, as the indication for TNFα inhibitor treatment was derived from the specialism of the prescriber, we were unable to make distinctions between the individual RD, such as RA, AS, psoriatic arthritis, and juvenile idiopathic arthritis. The gene discussed is TNF; the disease is juvenile idiopathic arthritis.